All Stories

  1. Long‐term cell fate and functional maintenance of human hepatocyte through stepwise culture configuration
  2. Multiomics Integration of Tuberculosis Pathogenesis
  3. Difluoromethylornithine (DFMO) and AMXT 1501 inhibit capsule biosynthesis in pneumococci
  4. Fatty acid metabolism of Mycobacterium tuberculosis: A double-edged sword
  5. A metabolic shift of M. tuberculosis required to adapt hypoxia
  6. Bacterial Protein Reshapes Host Defense toward Antiviral Responses
  7. Endothelial lineage-specific interaction of Mycobacterium tuberculosis with the blood and lymphatic systems
  8. Glutamate mediated metabolic neutralization mitigates propionate toxicity in intracellular Mycobacterium tuberculosis
  9. TRIM56-mediated monoubiquitination of cGAS for cytosolic DNA sensing
  10. Metabolic anticipation in Mycobacterium tuberculosis
  11. Two enzymes with redundant fructose bisphosphatase activity sustain gluconeogenesis and virulence in Mycobacterium tuberculosis
  12. Metabolomics: A window into the adaptive physiology of Mycobacterium tuberculosis
  13. Inactivation of Fructose-1,6-Bisphosphate Aldolase Prevents Optimal Co-catabolism of Glycolytic and Gluconeogenic Carbon Substrates in Mycobacterium tuberculosis
  14. Allostery and compartmentalization: old but not forgotten
  15. Methylcitrate cycle defines the bactericidal essentiality of isocitrate lyase for survival of Mycobacterium tuberculosis on fatty acids
  16. Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis
  17. Co-Immunization of Plasmid DNA Encoding IL-12 and IL-18 with Bacillus Calmette-Guérin Vaccine against Progressive Tuberculosis
  18. Synthesis of 4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate and Kinetic Studies of Mycobacterium tuberculosis IspF
  19. Expression and Characterization of Soluble 4-Diphosphocytidyl-2-C-methyl-D-erythritol Kinase from Bacterial Pathogens
  20. The Mycobacterium tuberculosis MEP (2C-methyl-d-erythritol 4-phosphate) pathway as a new drug target
  21. Chemoenzymatic synthesis of 4-diphosphocytidyl-2-C-methyl-d-erythritol: a substrate for IspE